The future of the global coronary heart disease diagnostic imaging devices market looks promising with opportunities in the computed tomography, x ray, ultrasound, magnetic resonance imaging, and nuclear medicine markets. The global coronary heart disease diagnostic imaging devices market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are growing prevalence of coronary artery diseases, increasing adoption of early diagnostic techniques, and the rising need for non-invasive diagnostic techniques.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the coronary heart disease
diagnostic imaging devices market by modality (computed tomography, X rays,
ultrasound,magnetic resonance imaging, nuclear medicine, and others), and
region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key factors
affecting market dynamics? What are the key challenges and business risks in
this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market, computed
tomography, x ray, ultrasound, magnetic resonance imaging, and nuclear medicine
are the major segments of coronary heart disease diagnostic imaging devices
market by modality. Lucintel forecasts that nuclear medicine will remain the
largest segment over the forecast period owing to its non-invasiveness, clarity
of image, and accurate detection of disease even at a nascent stage.
North America will
remain the largest segment over the forecast period due to the existence of
technologically sound medical staff, improved healthcare expenditure by the
government, and increasing number of cancer cases in the region.
GE Healthcare, Fujifilm,
Siemens, Toshiba, Hitachi, Koninklijke Phillips, Canon Medical Systems, and
Analogic are the major suppliers in the coronary heart disease diagnostic
imaging devices market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
10. Stretcher Market
No comments:
Post a Comment